PBM Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover and creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any. It relies on appropriations, grants, tax rate changes, and reporting requirements. The main policy areas are Finance, Environment, Healthcare, and Health.
Who Benefits and How
The main beneficiaries are the people, organizations, or agencies identified in the bill's substantive provisions.
Who Bears the Burden and How
Patients and health care consumers affected by the bill could lose revenue opportunities, Environmental and public health interests affected by the bill would take on compliance duties, and Businesses and employers affected by the bill would take on compliance duties.
Key Provisions
- Creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover...
- Creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover and creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any.
Key Policy Areas
Finance, Environment, Healthcare, Health
Primary Purpose
The bill creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover and creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any.
Policy Domains
Whole bill
Identified Costs
- Patients and health care consumers affected by the bill
- Environmental and public health interests affected by the bill
- Businesses and employers affected by the bill
- Federal, state, or local agencies responsible for implementing the clause
- Homeowners, tenants, or housing market participants affected by the bill
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on the Judiciary.
Introduced in Senate
Ms. Warren (for herself, Mr. Hawley, Mr. Fetterman, and Mr. …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology